Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Debt (2016 - 2023)

Marimed (MRMD) has disclosed Total Debt for 12 consecutive years, with $22.5 million as the latest value for Q3 2023.

  • On a quarterly basis, Total Debt changed N/A to $22.5 million in Q3 2023 year-over-year; TTM through Sep 2023 was $22.5 million, a N/A change, with the full-year FY2021 number at $17.3 million, up 45.79% from a year prior.
  • Total Debt was $22.5 million for Q3 2023 at Marimed, down from $24.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $24.1 million in Q2 2023 to a low of $46000.0 in Q1 2022.
  • A 5-year average of $8.9 million and a median of $5.4 million in 2020 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: plummeted 98.58% in 2022, then surged 52297.83% in 2023.
  • Marimed's Total Debt stood at $1.8 million in 2019, then soared by 574.76% to $11.8 million in 2020, then surged by 45.79% to $17.3 million in 2021, then plummeted by 99.73% to $46000.0 in 2022, then skyrocketed by 48802.17% to $22.5 million in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Total Debt are $22.5 million (Q3 2023), $24.1 million (Q2 2023), and $24.1 million (Q1 2023).